Farmak PJSC

00481198

Farmak

公共股份公司 (Public Joint Stock Company)

63, Frunze str.
Kyiv (基辅)
04080
Ukraine (乌克兰)

+380 44 496 87 87 

Iryna Radchenko 

http://farmak.ua/

该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

英语，俄语，乌克兰语

3004 由混合或非混合产品构成的治病或防病用药品（不包括品目3002、3005或3006的货品），已配定剂量（包括制成皮肤摄入形式的）或制成零售包装


药品、药用化学品及植物药材的制造
–在药物制造中取其药理特性的原料药的制造：抗生素、基本维生素、水杨酸和O-乙酰水杨酸等
–血液的加工
–下列药物的制造：
™. 抗血清和其他血液分离物
™. 疫苗
™. 各种药物，包括顺势医疗制剂
–外用化学避孕产品和激素避孕药的制造
–医用诊断制剂的制造，包括妊娠试剂
–放射性体内诊断物质的制造
–生物技术药品的制造
–化学纯糖的制造
–腺的加工和腺等提取物的制造等
–医用浸药软填充料、纱布、绑带、敷料等
–药用植物产品的制备(研磨、分选、碾压)


Asparginat K-Mg, Benzydamine, Calcium gluconate, Metformin, Gliclazide, Macrogol, Thioctic acid, Glimepiride, Domperidone, Insulin glargine , Human insulin (rDNA origin), Glibenclamide, L-Ornithine L-Aspartate, Omeprazole, Sodium picosulfate, Bismuth subcitrate, Enoxaparin sodium, Tranexamic acid, Dextrose, Clopidogrel, Acetylsalicylic acid, Amlodipine, Atorvastatin, Diosmin, Hesperidin, Bisoprolol, Enalapril, hydrochlorothiazide, Enalapril, Nifedipine, Metoprolol, Ramipril, Ramipril, hydrochlorothiazide, Toracemide, Menthyl isovalerate, Meldonium, Acyclovir, Naftifine Hydrochloride, Acyclovir, Terbinafine, Cyproterone, Progesterone, Hydroxyprogesterone, Testostеrone propionate, Betamethasone, Dexamethasone, Hydrocortisone , Potassium iodide, Levothyroxine sodium, Octreotide, Desmopressin, Cо-trimoxazole, Dioxydine, Itraconazole, Valaciclovir, Flutamide, Letrozole, Dexketoprofen, Diclofenac sodium, Chondroitin sulfate, Ketoprofen, Nimesulide, Meloxicam, Glucosamine sulphate sodium salt, Nalbuphine, Lamotrigine, Piracetam, Cinnarizine, Acetylsalicylic acid, Paracetamol, Caffeine, Ketamine hydrochloride, Citicoline, Citicoline, Gabapentin, Sodium oxybate , Pregabalіn, Piracetam, Betahistine, Vinpocetine, Zolmitriptan, Choline alfoscerate, Benzyl benzoate, Desloratadine, Phenylephrine, Dimethindene Maleate, Paracetamol, Phenylephrine, Theophylline, Xylometazoline, Hexetidine, Lysozyme hydrochloride, Dequalinium chloride, Loratadine, Naphazoline nitrate, Sodium chloride, Ambroxol hydrochloride, carbocisteine, Dry ivy leaf extract, Oxymetazoline, Brinzolamіd, Ciprofloxacine, Cromoglicic acid, Diclofenac Sodium, Dexamethasone, Travoprost, Latanoprost, Latanoprost, Tіmоlоl, Moxifloxacin, Timolol , Phenazone, Lidocaine Hydrochloride, Pilocarpinе hydrochloride, Sulfacil sodium, Tropicamide, Tetryzoline, Taurine, Taurine, Dexpanthenol, Dextrose, Gadopentetic acid, Iohexol, Sodium amidotrizoate

Our mission
We improve the quality of life, ensuring human right to get effective high-quality medicines.

Our vision
We strive to be the leader of the national pharmaceutical industry and a competitive player in the international markets.

Our values

People
We build relationships with each employee based on mutual responsibility and trust. We unlock the potential of each employee, ensuring Farmak's leadership and sustainable development.

Innovations
We understand innovations as constant improvements. The purpose of our focus on innovation is to reach company's main strategic goals rather than to get short-term benefits. 

Quality
We use modern scientific achievements in order to develop and produce medicines. High quality standards foster customers’ loyalty to our products.

When you buy our medicinal products, you can be sure of their quality, safety, and efficiency.

To this end, the Company has set up, implemented and continuously improves the pharmaceutical quality system in compliance with the regulatory requirements in force and the worldwide standards.

The system is intended to provide and constantly maintain the proper quality level of products and compliance with the requirements of the current good practices in the following systems: quality assurance, logistics, production, packaging and labeling, facilities and equipment, quality control, research and development, and improvement of the Company’s business processes.

The system compliance is confirmed by the national and European regulatory authorities.

System compliance is confirmed by the national and EU regulatory authorities:
- Manufacturer's authorization
- Importer's authorization
- Wholesale distribution authorization
- National certificates of GMP compliance for 16 manufacturing sites
- EU certificates of GMP compliance for 4 manufacturing sites:
     Germany: 1 site
     Poland: 3 sites
- Certificates of compliance with ISO 9001, ISO 13485
- Certificate of Accreditation for quality control laboratories to control the quality and safety of the medicinal products
- Certificate of Accreditation to measure the site parameters within the scope of accreditation
- Sustainable environmental balance is a key component of the responsible business of Farmak. The Company's strategy aims to ensure efficient use of natural resources, environmental protection and safety.

We are well aware that natural resources are exhaustible, and do the best to preserve it for future generations. Therefore, we try to minimize the environmental impact. To this end, the Company has implemented the environmental management system in accordance with DSTU ISO 14001:2006 (Environmental Management System).

Farmak has realized major investment projects to mitigate the environmental impact. We recycle resources. For example, following materials were transferred for recycling in 2015: stretch film - 8.025 tons, waste plastic - 20.118 tons, glass scrap - 14.820 tons, waste paper and cardboard - 152.605 tons. The share of re-used water is constantly growing.

We accept responsibility for the environment and recognize importance of sustainable development, so we introduce innovative and energy efficient technologies. We understand that the environmental safety should be ensured at every production stage, so responsible attitude to environmental issues is among the top priorities of the Company. We care about eco-awareness and culture of our workers.

We are responsible for the environment!